Optofluidic Bioassay

Optofluidic Bioassay is a University of Michigan spin-off formed to develop microfluidic technologies that make ELISA (enzyme-linked immunosorbent assay) faster, lower-cost, and more accessible.

We are pleased to announce that in collaboration with the University of Michigan, Optofluidic Bioassay’s product Express ELISA system (WO2018165354A1, US20190383750A1, CN110402383A, EP3593117A1) invented by Maung Khaing Oo (lead inventor) and Xudong Fan (co-inventor) enables to detect SARS-CoV-2 specific IgG and viral antigen – S protein in serum rapidly (less than 20 minutes) and quantitatively. Furthermore, the system consumes less than 10 microliters sample (10-20% of traditional ELISA sample).